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Abstract
Background: Large-scale human sequencing projects have described around a hundred-million single nucleotide
variants (SNVs). These studies have predominately involved individuals with European ancestry despite the fact that
genetic diversity is expected to be highest in Africa where Homo sapiens evolved and has maintained a large
population for the longest time. The African Genome Variation Project examined several African populations but
these were all located south of the Sahara. Morocco is on the northwest coast of Africa and mostly lies north of the
Sahara, which makes it very attractive for studying genetic diversity. The ancestry of present-day Moroccans is
unknown and may be substantially different from Africans found South of the Sahara desert, Recent genomic data
of Taforalt individuals in Eastern Morocco revealed 15,000-year-old modern humans and suggested that North
African individuals may be genetically distinct from previously studied African populations.
Results: We present SNVs discovered by whole genome sequencing (WGS) of three Moroccans. From a total of
5.9 million SNVs detected, over 200,000 were not identified by 1000G and were not in the extensive gnomAD
database. We summarise the SNVs by genomic position, type of sequence gene context and effect on proteins
encoded by the sequence. Analysis of the overall genomic information of the Moroccan individuals to individuals
from 1000G supports the Moroccan population being distinct from both sub-Saharan African and European populations.
Conclusions: We conclude that Moroccan samples are genetically distinct and lie in the middle of the previously
observed cline between populations of European and African ancestry. WGS of Moroccan individuals can identify a large
number of novel SNVs and aid in functional characterisation of the genome.
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Background
The accepted model of human evolution is that Homo
sapiens appeared in Africa around 200,000 years ago [1].
Adaptation to modern humans probably occurred grad-
ually in several different locations [2]. Until recently, the
oldest H. sapiens fossils were from Ethiopia, dated as
195,000 years old [3]. However, fossils discovered in
Morocco have been re-dated as 300,000 years old [4].
There is evidence of modern humans in North Africa
from about 160,000 years ago [5, 6]. Populations outside
of Africa are thought to have all originated by serial
colonisation from Africa [2] and still retains a greater
genetic diversity within Africa than in any other region
[7]. However, the majority of genome sequencing studies
have largely excluded Northern African individuals [8].
Understanding this missing diversity can help to illumin-
ate fundamental function within the human genome.
Sequencing Moroccan individuals may reveal variants
that can contribute to our understanding of human biol-
ogy and disease.
A major application of genomics is understanding the
causes of human disease. Nearly all diseases have a gen-
etic component but every individual carries millions of
variations from the reference genome and therefore pin-
pointing pathogenic variants is extremely challenging.
Characterising the full spectrum of human genome vari-
ation in healthy individuals is a valuable step and neces-
sarily this includes wide sampling of different populations.
While many variations are seen in multiple populations,
some are variations are restricted or very rare. The pattern
of variation can also tell us about human evolution and
migration.
Genetic analysis of mtDNA and Y-chromosomes showed
that North African populations are mixtures of autochthon-
ous and populations from the Middle East, Europe and
sub-Saharan Africa [9]. The human history of North Africa
is characterised by multiple migration movements, admix-
tures and founder effects. Recent genomic sequence of indi-
viduals from North African supports the theory of back-to-
Africa migration in the pre-Holocene period ~ 12,000 years
ago when the Berbers tribe migrated from Arabia [10]. This
was followed by many population movements resulting
from invasions and migrations by such groups as the
Phoenicians, Romans, Vandals, Byzantines, Jew, Arab
and more recently Spanish and French [11].
For many centuries, North African populations have
been mistakenly viewed as continuous with sub-Saharan
populations. However, Arredi et al. in 2004 showed that
North African populations have predominantly Neolithic
origin using Y-chromosome DNA markers [12]. Analysis
of SNVs from 2099 individuals in 43 populations showed
that North African populations are closer to European
and Near East than they are to Sub-Saharan populations
[7]. More recently, gene flow from North Africa enriches
genetic diversity in southern Europe, which is not the
case for Sub-Saharan populations. In fact, between 4 and
20% of Southwestern European genomes were assigned
to North African ancestral cluster whereas only Sub-
Saharan ancestry was detected at < 1% in Europe [7].
The North African population, which exceeds 160 million
people, has not been represented in international genome
sequence consortiums including the 1000 Genomes Project
(1000G) and The African Genome Variation Project. To
further characterise the North African genome and estab-
lish relationship with genomes from other ethnical groups
we decided to perform whole genome sequencing (WGS)
of three individuals from North Africa. We propose that
the distinct genetics of North African’s should be a focus
for characterising (dys) function within the human genome.
Results
Sequencing
Sequencing produced 487 million paired-end reads for
the first sample and approximately half that number for
the other two samples. Over 99.7% of reads mapped to
the reference for all samples. The mean depth was 30X
for the first sample and 16X for the other samples. The
percentage coverage of the samples at 10X was 88-92%.
Quality control
To design quality control, the distribution of values for
pairs of metrics was compared for true (matching alleles
in HapMap phase 3 or the Omni 2.5M SNP chip) and
other SNV sites. The starting ratio of true to other sites
was 0.72. The first filtering threshold applied was − 2.5 <
MQRankSum< 1 and QD > 7 or QD > 0.5 and − 0.01 <
MQRankSum< 0.01; this retained 99.61% of true sites
and had a discrimination factor of 1.088. The second
threshold was MQ > 50 or FS = 0 and MQ > 40; this
retained 99.4% of remaining true sites and had a dis-
crimination factor of 1.054. VariantRecalibration was
then run on the remaining SNVs with DP, SOR, Read-
PosRankSum and FS as input metrics. The option --maxI-
terations had to be increased to 500. The output graphs
were greatly improved from the first attempt and satisfac-
tory. GATK’s ApplyRecalibration was used to add
VQSLOD scores to the VCF file. A threshold of
VQSLOD>-0.5 was chosen. This retained 99.8% of
remaining true sites with a discrimination factor of 1.024.
The overall process retained 99.2% of true sites and in-
creased the ratio of true to other sites by 17%; 9% of SNVs
were removed. After quality control, there were 5,881,260
biallelic SNVs and 5359 multiallelic SNVs (Fig. 1a).
A high proportion of Moroccan SNVs are novel and
predicted to be functional
There were 215,691 SNV sites (4769 multiallelic) that
were not reported in 1000G. A further 3600 sites
Crooks et al. BMC Genetics          (2020) 21:111 Page 2 of 8
discovered in 1000G had a different allele in the Moroc-
can individuals. There was a concentration of novel
SNVs on chromosome 5 and a very high number of
novel SNVs between 30 and 40Mb on chromosome 6
(Fig. 1b). In view of this surprising finding we checked
whether it could be an artefact related to variant filtering
by 1000G [13]; a similar comparison with gnomAD SNV
sites (version 2.1.1) does not retain the peak on
chromosome 6 suggesting that this result was indeed
artefactual (Fig. 1c). Overall we identified 55,042 SNV
sites that were not identified in gnomAD. Only 1% of
SNV sites had missing genotypes. A small number, 0.6%,
of the SNV alleles were located in exons or splice sites;
interestingly novel SNVs were enriched in these regions
(Fig. 2b). Moreover, 1.5% of novel exon SNVs were non-
sense variants which is 4-fold higher the value for
Fig. 1 Distribution of SNV sites across the genome. Number of SNVs is shown for 10 Mb blocks of each chromosome. Lines indicate chromosome
boundaries. Shaded area is chromosome 5. a All SNV sites identified in the Moroccan individuals. b SNV sites with alleles not found in
1000G. c SNV sites with alleles not found in gnomAD. The value for 30-40 Mb on chromosome 6 was highest, at 4094, but is omitted to
better represent the majority of the genome. No values are shown for the Y chromosome because GnomAD did not make calls for
this chromosome
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reference and novel alleles combined (Fig. 2c). Overall
these observations are consistent with significant num-
bers of high impact novel variants within Moroccan
individuals.
Moroccan genomes form a distinct population
We then analysed the entire Moroccan genomes by
principal components analysis to determine similarity to
1000G populations. Data projected onto PC1 and PC2
calculated from 1000G placed the Moroccans between
European and African 1000G populations (Fig. 3).
Discussion
Sequencing new populations is important to understand
the diversity and ultimately function of the human gen-
ome. The Moroccan population has been neglected in
Fig. 2 Properties of discovered SNVs. Results are shown for all SNV alleles, alleles not found in 1000G and alleles not found in gnomAD. Light
grey bars are percentage of all alleles in each class, black are percentage of alleles novel to 1000G in each class, and dark grey are percentage of
alleles novel to gnomAD in each class. a Distribution of number of copies of the alternative allele in the three Moroccan individuals. b
Distribution of alleles across different types of sequence. c For exonic alleles, distribution of functional effects. For (b) and (c), the Y axis is log10
scaled and annotation was performed in ANNOVAR version 16-04-18 with the RefSeq gene model
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part because of assumptions that it is not distinct and
offers little new information. Our study demonstrates
that this is not the case. In fact, Moroccans harbour a
large number of novel SNVs and are genetically distinct
from European and Sub-Saharan populations.
The study of pathogenic genetic variation rests upon
successful filtering of likely benign variants. Large scale
population studies such as gnomAD [14] have signifi-
cantly advanced this effort by distinguishing common
from rare variants; rare variants are more likely to be
under negative selection and therefore pathogenic. The
amount of new information per genome is maximised
when individuals are drawn from different populations.
Our study demonstrates that Moroccans carry a large
number of high impact genomic variants in coding re-
gions. None of the individuals in this study suffered a
genetic disease at the age of sampling and therefore it is
likely that much of the genetic variation we have de-
scribed is benign and should be excluded in future at-
tempts to define the genetic architecture of diseases.
A high number of novels SNVs were found in a region of
chromosome 6 and on chromosome 5 however further
analysis suggests that this may have been an artefact related
to 1000G methodology. This is an important finding which
may be useful for other similar population genetics work.
Conclusions
WGS in three Moroccan individuals without significant
pathology identified a relatively large number of novel
SNVs particularly within conserved coding regions. We
conclude that focused inclusion of Moroccan individuals
in future population-level WGS studies is a cost-
effective method to maximise the discovery and charac-
terisation of human genetic variation.
Methods
Sample selection and sequencing
Volunteers from different Moroccan regions in the far
West of Africa, were recruited in Specialised Hospital of
Rabat. All participants were informed regarding the
study and written consent was obtained from them ac-
cording to research protocol presented and approved by
local research committee of the Faculty of Medicine and
Pharmacy at the University Mohammed V in Rabat.
Blood samples were coded and DNA was extracted
according to standard protocol. Three samples were ran-
domly chosen for sequencing including one Arab
speaker and two Berber speakers; a language was
assigned based on the language spoken by all members
of the preceding three generations. The samples were
paired-end whole genome sequenced on an Illumina
HiSeq 2500 with a 100 bp read length. The first sample
was run on five lanes across three Rapid Runs. The other
two samples were each run on a single lane in High-
Output Mode. FASTQ files were produced for each lane
and sample by bcl2fastq (version 1.8.4) with adapter
trimming and allowing a single mismatch in the index
sequence.
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Fig. 3 Inferred shared ancestry of Moroccan individuals to global populations. The first (PC1) and second (PC2) principle components of
individuals from 1000G and the Moroccan individuals are shown. Principle components were calculated from the genotype matrix of high-quality, LD-
pruned SNPs from 1000G. The Moroccan individuals were genotyped at the same sites and values predicted with the same model. Three letter codes
in the legend are from 1000G. The continental areas of the populations are as follows: ACB, ASW, ESN, GWD, LWK, MSL and YRI - Africa; CLM, MXL, PEL
and PUR - the Americas; CDX, CHB, CHS, JPT and KHV - East Asia; CEU, FIN, GBR, IBS and TSI - Europe; BEB, GIH, ITU, PJL, STU - South Asi
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Variant calling
Reads were aligned to the build 37 version of the human
reference genome with decoy sequences that was used in
phase 3 of 1000G, using the MEM algorithm in BWA
(version 0.7.15a). Duplicate reads were marked by Picard
(version 2.8.0). For the first sample, alignment and dupli-
cate marking was performed per lane; the data were then
merged into a single BAM file with Picard and duplicate
marking repeated. Base quality scores were adjusted by
BQSR from GATK (version 3.7). Alignment statistics
were generated with flagstat from SAMtools (version
1.3.1) and depth and coverage statistics were produced
using GATK’s DepthOfCoverage restricted to the auto-
somes and with a minimum base quality of 10 and mini-
mum mapping quality of 20. A gVCF file of all sites was
generated for each sample by GATK’s HaplotypeCaller
with the options --emitRefConfidence BP_RESOLUTION.
One VCF file of all sites with evidence of a difference from
the reference in any sample was produced from the three
gVCFs with GATK’s GenotypeGVCFs.
Quality control
Sites in the VCF file were excluded if the metric QD was
absent, the metric DP (in the sample data) was zero for
all samples, or the metric AD was zero for all alternative
alleles in all samples. Sites outside the autosomes were
excluded. The intention was to perform variant quality
control using GATK’s VQSR. VQSR models a new site
metric (VQSLOD) from selected metrics by machine
learning on the dataset. The algorithm trains on a subset
of sites that are defined as true sites (sites in the dataset
that are in HapMap phase 3 or the Omni 2.5M SNP
chip). VariantRecalibrator was run in SNP mode with
QD, MQ, MQRankSum, ReadPosRankSum, FS, SOR and
DP as input metrics. However, VQSR output graphs sug-
gested poor performance perhaps due to the small sam-
ple size; the probability density function (PDF) was not
smooth, with low and high values interspersed, and no
clear pattern across the parameter space; and the fre-
quency distributions of MQ and MQRankSum in the
true sites had a sharp spike, which may have affected the
model fitting because VQSR assumes metrics are nor-
mally distributed. We therefore investigated first exclud-
ing sites by threshold values for MQ and MQRankSum
and then running VariantRecalibrator without those
metrics. Quality control was only developed for single
nucleotide variants (SNVs). Given the difficulties of
quality control for SNVs and the higher error rate for
calling insertions or deletions (INDELs), all further ana-
lysis was with SNVs only.
To choose threshold values MQ and MQRankSum,
the distribution of values in the VCF file for pairs of the
seven metrics were examined using R (version 3.3.1).
Metrics were inspected in pairs so the joint distribution
across the values of two metrics could be seen. Adopting
the technique of a set of true sites, SNV sites were classi-
fied as either true or other. True sites had alleles match-
ing SNPs in HapMap phase 3 or the Omni 2.5 M SNP
chip. Frequency distributions were compared for true
and other sites to identify ranges of values that were
seen at other sites but were rare at true sites. Different
thresholds were evaluated by the percentage of true sites
kept and the ratio of this to the percentage of other sites
kept. This ratio will be described as the discrimination
factor because it is the factor by which the ratio of true
to other sites is increased by filtering.
Identification of novel SNVs
The quality controlled SNVs were compared to the
SNVs from phase 3 of 1000G (version 5a, [15]). 1000G
discovered over 80 million SNVs from whole genome se-
quencing 2535 individuals. The 1000G VCF file includes
multiallelic sites where alleles are written in a complex
way to enable SNVs and indels to be represented at the
same site. A custom Perl script was used to separate al-
leles and convert them to standard notation and left
align INDELs. SNV alleles in the Moroccan individuals
that were not reported in 1000G were determined. The
distribution of SNV sites and sites with alleles not in
1000G across the genome was explored by dividing each
chromosome into 10Mb blocks. Custom Perl scripts
were written for this and other analyses.
SNVs were also compared to SNVs in the Genome
Aggregation Database (gnomAD, [14] version 2.1.1), ge-
nomes data. The data in gnomAD are an amalgamation
from multiple large-scale sequencing studies, primarily
disease case-control studies, totalling 15,708 genomes.
Individuals with severe childhood-onset diseases and
their first-degree relatives were removed and a set of un-
related samples were selected for gnomAD. The gno-
mAD variant set was generated by reanalysing the
original FASTQ files through a single pipeline followed
by joint variant-calling. GnomAD provides all called var-
iants with flags for those that failed quality control. To
reduce the chance of novel SNVs being false positives,
we determined alleles that were not in gnomAD and al-
leles that were called by gnomAD but filtered out for
quality were excluded. GnomAD genomes does not have
Y chromosome variants so these could not be compared.
The distribution of SNV sites with novel alleles not in
gnomAD was assessed in the same way as for alleles not
in 1000G.
SNV characterisation
The number of copies of the non-reference alleles in the
Moroccan individuals was counted. SNV sites where
there was no genotype call for one or more individuals
were excluded. The allele count spectrum was also
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evaluated for SNVs novel to 1000G and SNVs novel to
gnomAD.
The filtered VCF file was converted into the input for-
mat for ANNOVAR (version 16-04-2018) including re-
writing all multiallelic sites so that each allele was on a
separate line, with a custom Perl script. RefSeq (version
x) gene annotations were added with ANNOVAR’s an-
notate_variation.pl program and the option -separate,
which provides annotations for all alternative transcripts.
The number of alleles in different types of sequence was
determined from the variant_function output file. Each
allele was allocated to only one type; precedence for
multiple annotations was, from high to low, exonic or
splicing (within the first or last two bases of an intron),
ncRNA_exonic (non-coding RNA exonic) or ncRNA_spli-
cing, UTR5 or UTR3, intronic, ncRNA_intronic, upstream
or downstream, intergenic. For exonic alleles, the number
with different functional effects was determined from the
exonic_variant_function output file. Each allele was allo-
cated to only one effect; the precedence for multiple anno-
tations was stop-gain, stop-loss, non-synonymous SNV,
synonymous SNV or unknown. The distribution of SNV
alleles across sequence type and functional effects was also
measured for alleles novel to 1000G and alleles novel to
gnomAD.
Inference of Moroccan ancestry from genome-wide
pattern of variation
The Moroccan samples were projected onto the first
two principal components from a principal component
analysis (PCA) of 1000G samples. Phase 3 (version 5a)
of 1000G was used. A high quality, representative set of
SNVs was selected as follows. Biallelic sites on the auto-
somes with a minor allele frequency > 5% were extracted.
Any that were within 5 bp of another SNV or INDEL
were excluded. The genotypes for these SNVs were
loaded into PLINK/SEQ (version 0.10) and only SNVs
within the 1000G phase 3 ‘Strict’ mask that did not devi-
ate from Hardy-Weinberg equilibruim (P value≥10-6)
were retained. Genotypes at these SNVs were recalled
for the Moroccan samples with GATK’s Genoty-
peGVCFs with the options -L, −ip 100 and --include-
NonVariantSites as nearly a third of the sites were not in
the original VCF file. A small number (0.1%) of sites
were still not called and were excluded. The genotypes
were unchanged for sites that were in the original VCF
file. Sites that had been excluded in the Moroccan sam-
ples for quality control, were within 5 bp of another vari-
ant in the Moroccan data or had a different alternative
allele from 1000G were removed. SNVs were also fil-
tered based on site and sample metrics in the Moroccan
data; sites that were homozygote reference for all sam-
ples were kept if they had QUAL≥30, and DP ≥ 10 and
RGQ ≥ 20 for all samples; variant sites were kept if they
had DP ≥ 10 and GQ ≥ 20 for all samples. Filtering based
on the Moroccan data excluded 22% of the selected
1000G sites.
The 1000G genotypes for the high-quality sites were
loaded into PLINK (version 1.07). SNVs within two re-
gions of extended LD (chr6:25,000,000-35,000,000 and
chr8:7,000,000-14,000,000) were removed then LD prun-
ing was performed with the options --indep 50 5 2. This
resulted in 310,000 SNVs for PCA. The 1000G geno-
types were replaced with indicator variables 0, 1, 2, equal
to the number of alternative alleles present. Principle
components were calculated in R by the prcomp func-
tion with options centre = TRUE and scale = T. Principle
component values for the Moroccan individuals were
calculated from the 1000G model with the predict
function.
Availability of data and materials: all data are available at
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